Microwave ablation: A new technique for the prophylactic management of idiopathic recurrent epistaxis
The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation. Case series with chart review. 61 patients with idiopathic recurrent epistaxis but no defin...
Saved in:
Published in | American journal of otolaryngology Vol. 40; no. 5; pp. 696 - 699 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2019
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0196-0709 1532-818X 1532-818X |
DOI | 10.1016/j.amjoto.2019.06.005 |
Cover
Abstract | The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.
Case series with chart review.
61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.
Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1–2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.
MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified. |
---|---|
AbstractList | The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.
Case series with chart review.
61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.
Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.
MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified. The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.OBJECTIVEThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.Case series with chart review.STUDY DESIGNCase series with chart review.61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.SUBJECTS AND METHODS61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.Rebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.RESULTSRebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1-2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.MWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified.CONCLUSIONSMWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified. ObjectiveThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic microwave ablation (MWA) or continuous observation.Study designCase series with chart review.Subjects and methods61 patients with idiopathic recurrent epistaxis but no definite bleeding sites in the first operation were assigned to prophylactic MWA group (n = 39) and continuous observation group (n = 22). Patients in prophylactic MWA group were given prophylactic MWA at the common bleeding sites. Patients in continuous observation group were only observed in the ward. The bleeding sites, re-bleeding and complications were evaluated during 3 months follow-up period.ResultsRebleeding was experienced by 7 of the patients (17.9%) who were treated with prophylactic MWA whereas, 13 of the patients (59.1%) who used continuous observation had rebleeding. The rebleeding rate for patients undergoing prophylactic MWA group was lower than that for the observation-only group (p < 0.01). All the ablations were completed for the patients with known bleeding site within 1–2 min. These patients only had the complain of slight postoperative pain, no serious complications (including nasal adhesion, crust, septal perforation, etc.) were found in the follow-up period.ConclusionsMWA is a simple, convenient, rapid, and definite hemorrhage control method with minimally invasive therapeutic technique. Prophylactic MWA at the common bleeding sites helps to significantly reduce the rate of rebleeding in patients in whom no definite bleeding sites have been identified. |
Author | Lou, Zheng-cai |
Author_xml | – sequence: 1 givenname: Zheng-cai surname: Lou fullname: Lou, Zheng-cai email: louzhengcai@163.com organization: Department of Otorhinolaryngology, Yiwu Central Hospital, 699, Jiangdong Road, Yiwu City, Zhejiang Province, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31229366$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU2LFDEYhIOsuLOr_0Ak4MVLt_nqdHoRYVn8ghUvCt5CJv22k7E7aZP0rvPvzTirh7nMKZD3qaKoukBnPnhA6DklNSVUvt7WZtqGHGpGaFcTWRPSPEIr2nBWKaq-n6FVOciKtKQ7RxcpbQkhXPDmCTrnlLGOS7lC8NnZGO7NHWCzHk12wV_ha-zhHmewG-9-LYCHEHHeAJ5jmDe70djsLJ6MNz9gAp9xGLDrXZhN3pRDBLvEuP-H2aVsfrv0FD0ezJjg2cN7ib69f_f15mN1--XDp5vr28oKwXNliaS9YkyuRUPZmra2Y8yAaixpG2GhIVIOoMRAhSRNQ0UnO9KBarkSikHLL9Grg29JWoKnrCeXLIyj8RCWpBkTknHBeFfQl0foNizRl3SFUpQIRVtVqBcP1LKeoNdzdJOJO_2vwAKIA1BaTCnC8B-hRO930lt92Envd9JE6rJTkV0dyazLf9vP0bjxlPjtQQylyjsHUSfrwFvoXek-6z64UwZvjgzs6LyzZvwJu9PyP8rVw_k |
CitedBy_id | crossref_primary_10_1016_j_amjoto_2021_102916 crossref_primary_10_1186_s40463_021_00520_2 crossref_primary_10_1016_j_amjoto_2020_102494 crossref_primary_10_1016_j_amjoto_2020_102492 crossref_primary_10_1016_j_amjoto_2020_102519 |
Cites_doi | 10.1002/alr.22304 10.1080/00016489.2018.1552016 10.1016/j.anl.2015.09.015 10.1097/01.mlg.0000161365.96685.6c 10.1017/S0022215110000411 10.1007/s12070-010-0054-0 10.1080/02656736.2017.1388929 10.1177/014556130408300913 10.2147/OTT.S151219 |
ContentType | Journal Article |
Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. 2019. Elsevier Inc. |
Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. – notice: 2019. Elsevier Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7QR 7TK 8FD FR3 K9. NAPCQ P64 7X8 |
DOI | 10.1016/j.amjoto.2019.06.005 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Chemoreception Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Biotechnology Research Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Nursing & Allied Health Premium |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-818X |
EndPage | 699 |
ExternalDocumentID | 31229366 10_1016_j_amjoto_2019_06_005 S0196070919303977 |
Genre | Journal Article Comparative Study |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1CY 1P~ 1RT 1~. 1~5 23M 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIWK ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CAG COF CS3 EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HEA HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LZ2 M29 M41 MO0 N4W N9A O-L O9- OAUVE OG- OR0 OZT P-8 P-9 PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SJN SSH SSZ SV3 T5K WH7 WOW WUQ X7M Z5R ZGI ~G- 3V. 7RV 7X7 8FI AACTN AAIAV ABLVK ABYKQ AFKRA AFKWA AHPSJ AJBFU AJOXV AMFUW AZQEC BENPR EFLBG FYUFA GUQSH LCYCR M1P M2O RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7QO 7QR 7TK 8FD FR3 K9. NAPCQ P64 7X8 |
ID | FETCH-LOGICAL-c443t-c061d8226b4512b17c922ae85c0754ce5066fe84f1460551496909e8738482e73 |
IEDL.DBID | AIKHN |
ISSN | 0196-0709 1532-818X |
IngestDate | Thu Sep 04 19:01:53 EDT 2025 Sat Jul 26 02:19:46 EDT 2025 Wed Feb 19 02:28:59 EST 2025 Thu Apr 24 23:09:46 EDT 2025 Tue Jul 01 03:15:19 EDT 2025 Fri Feb 23 02:30:36 EST 2024 Tue Aug 26 18:39:46 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Observation Epistaxis Microwave ablation Re-bleeding |
Language | English |
License | Copyright © 2019 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c443t-c061d8226b4512b17c922ae85c0754ce5066fe84f1460551496909e8738482e73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 31229366 |
PQID | 2281048178 |
PQPubID | 1226367 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_2246234239 proquest_journals_2281048178 pubmed_primary_31229366 crossref_primary_10_1016_j_amjoto_2019_06_005 crossref_citationtrail_10_1016_j_amjoto_2019_06_005 elsevier_sciencedirect_doi_10_1016_j_amjoto_2019_06_005 elsevier_clinicalkey_doi_10_1016_j_amjoto_2019_06_005 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September-October 2019 2019-09-00 2019 Sep - Oct 20190901 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 09 year: 2019 text: September-October 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Maryland Heights |
PublicationTitle | American journal of otolaryngology |
PublicationTitleAlternate | Am J Otolaryngol |
PublicationYear | 2019 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Guo, Tian, Zhao, Jiang (bb0030) 2018; 11 Thornton, Mahesh, Lang (bb0015) 2005; 115 Paul, Kanotra, Kanotra (bb0050) 2011; 63 Iimura, Hatano, Ando, Arai, Arai, Shigeta (bb0005) 2016; 43 Zhou, Wu, Ling, Zhu, Lu, Wang (bb0025) 2018; 34 Lou, Wei, Lou (bb0040) 2019 Lou, Dong, Lou (bb0035) 2019 Bhatnagar, Berry (bb0045) 2004; 83 Supriya, Shakeel, Veitch, Ah-See (bb0010) 2010; 124 Liu, Sun, Guo, Wang (bb0020) 2016; 95 Liu (10.1016/j.amjoto.2019.06.005_bb0020) 2016; 95 Supriya (10.1016/j.amjoto.2019.06.005_bb0010) 2010; 124 Guo (10.1016/j.amjoto.2019.06.005_bb0030) 2018; 11 Bhatnagar (10.1016/j.amjoto.2019.06.005_bb0045) 2004; 83 Paul (10.1016/j.amjoto.2019.06.005_bb0050) 2011; 63 Iimura (10.1016/j.amjoto.2019.06.005_bb0005) 2016; 43 Lou (10.1016/j.amjoto.2019.06.005_bb0040) 2019 Thornton (10.1016/j.amjoto.2019.06.005_bb0015) 2005; 115 Zhou (10.1016/j.amjoto.2019.06.005_bb0025) 2018; 34 Lou (10.1016/j.amjoto.2019.06.005_bb0035) 2019 32334920 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102494 32334924 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102492 |
References_xml | – volume: 34 start-page: 1049 year: 2018 end-page: 1052 ident: bb0025 article-title: Application of microwave ablation in the emergent control of intraoperative life-threatening tumor hemorrhage during hepatic surgeries publication-title: Int J Hyperthermia – volume: 63 start-page: 141 year: 2011 end-page: 144 ident: bb0050 article-title: Endoscopic management of posterior epistaxis publication-title: Indian J Otolaryngol Head Neck Surg – volume: 83 start-page: 633 year: 2004 end-page: 634 ident: bb0045 article-title: Selective surgicel packing for the treatment of posterior epistaxis publication-title: Ear Nose Throat J – volume: 115 start-page: 588 year: 2005 end-page: 590 ident: bb0015 article-title: Posterior epistaxis: identification of common bleeding sites publication-title: Laryngoscope – volume: 43 start-page: 298 year: 2016 end-page: 303 ident: bb0005 article-title: Study of hemostasis procedures for posterior epistaxis publication-title: Auris Nasus Larynx – volume: 11 start-page: 1395 year: 2018 end-page: 1402 ident: bb0030 article-title: Fast hemostasis: a win-win strategy for ultrasound and microwave ablation publication-title: Onco Targets Ther – volume: 124 start-page: 744 year: 2010 end-page: 749 ident: bb0010 article-title: Epistaxis: prospective evaluation of bleeding site and its impact on patient outcome publication-title: J Laryngol Otol – year: 2019 ident: bb0035 article-title: Microwave ablation for the treatment of arterial epistaxis: “how I do it” publication-title: Int Forum Allergy Rhinol – year: 2019 ident: bb0040 article-title: Identification of bleeding sites and microwave thermal ablation of posterior epistaxis publication-title: Acta Otolaryngol – volume: 95 start-page: E18 year: 2016 end-page: E22 ident: bb0020 article-title: Posterior epistaxis: common bleeding sites and prophylactic electrocoagulation publication-title: Ear Nose Throat J – year: 2019 ident: 10.1016/j.amjoto.2019.06.005_bb0035 article-title: Microwave ablation for the treatment of arterial epistaxis: “how I do it” publication-title: Int Forum Allergy Rhinol doi: 10.1002/alr.22304 – year: 2019 ident: 10.1016/j.amjoto.2019.06.005_bb0040 article-title: Identification of bleeding sites and microwave thermal ablation of posterior epistaxis publication-title: Acta Otolaryngol doi: 10.1080/00016489.2018.1552016 – volume: 43 start-page: 298 year: 2016 ident: 10.1016/j.amjoto.2019.06.005_bb0005 article-title: Study of hemostasis procedures for posterior epistaxis publication-title: Auris Nasus Larynx doi: 10.1016/j.anl.2015.09.015 – volume: 95 start-page: E18 year: 2016 ident: 10.1016/j.amjoto.2019.06.005_bb0020 article-title: Posterior epistaxis: common bleeding sites and prophylactic electrocoagulation publication-title: Ear Nose Throat J – volume: 115 start-page: 588 year: 2005 ident: 10.1016/j.amjoto.2019.06.005_bb0015 article-title: Posterior epistaxis: identification of common bleeding sites publication-title: Laryngoscope doi: 10.1097/01.mlg.0000161365.96685.6c – volume: 124 start-page: 744 year: 2010 ident: 10.1016/j.amjoto.2019.06.005_bb0010 article-title: Epistaxis: prospective evaluation of bleeding site and its impact on patient outcome publication-title: J Laryngol Otol doi: 10.1017/S0022215110000411 – volume: 63 start-page: 141 year: 2011 ident: 10.1016/j.amjoto.2019.06.005_bb0050 article-title: Endoscopic management of posterior epistaxis publication-title: Indian J Otolaryngol Head Neck Surg doi: 10.1007/s12070-010-0054-0 – volume: 34 start-page: 1049 year: 2018 ident: 10.1016/j.amjoto.2019.06.005_bb0025 article-title: Application of microwave ablation in the emergent control of intraoperative life-threatening tumor hemorrhage during hepatic surgeries publication-title: Int J Hyperthermia doi: 10.1080/02656736.2017.1388929 – volume: 83 start-page: 633 year: 2004 ident: 10.1016/j.amjoto.2019.06.005_bb0045 article-title: Selective surgicel packing for the treatment of posterior epistaxis publication-title: Ear Nose Throat J doi: 10.1177/014556130408300913 – volume: 11 start-page: 1395 year: 2018 ident: 10.1016/j.amjoto.2019.06.005_bb0030 article-title: Fast hemostasis: a win-win strategy for ultrasound and microwave ablation publication-title: Onco Targets Ther doi: 10.2147/OTT.S151219 – reference: 32334924 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102492 – reference: 32334920 - Am J Otolaryngol. 2020 Nov - Dec;41(6):102494 |
SSID | ssj0003435 |
Score | 2.2230256 |
Snippet | The objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either prophylactic... ObjectiveThe objective of this study was to compare the re-bleeding of idiopathic recurrent epistaxis with no definite bleeding site treated with either... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 696 |
SubjectTerms | Ablation Adult Bleeding Cohort Studies Comorbidity Complications Endoscopy Epistaxis Epistaxis - prevention & control Epistaxis - therapy Female Hemorrhage Hospitals Humans Male Microwave ablation Microwaves - therapeutic use Middle Aged Nose Observation Observation - methods Otolaryngology Pain Patients Perforation Prognosis Prospective Studies Radiofrequency Ablation - methods Re-bleeding Recurrence Risk Assessment Systemic diseases Treatment Outcome |
Title | Microwave ablation: A new technique for the prophylactic management of idiopathic recurrent epistaxis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0196070919303977 https://dx.doi.org/10.1016/j.amjoto.2019.06.005 https://www.ncbi.nlm.nih.gov/pubmed/31229366 https://www.proquest.com/docview/2281048178 https://www.proquest.com/docview/2246234239 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-NAEB-0wuGL3JdaT2UPfM21-5Vs7q3ISe-O-nIKvi2b7RYitilaP578251JNgFBUe4l0CRDt5PdmV-6v_kNwNEw8CIzqSfxQZ8oo3TilBziIS30VHMvai29yWk6Pld_LvTFGhy3tTBEq4yxv4npdbSOZwbRm4NlWQ7-kbILTtgcIciQYMw6bAiZp7oHG6Pff8enXUCWqumzyYlviwZtBV1N83Lzy2pFVYA8r4U8qY_dyxnqNQRaZ6KTj7AVISQbNaP8BGth8Rk-TOIm-RcIEyLZ3bu7wFzRUN1-shFD_Mw6xVaGWJUh9mP4bejoq7pUis07LgyrZqycllXdsNiza_pXnnScWFgS4Hwob77C-cmvs-NxErspJF4puUo8Zu4pwoG0UJjkC575XAgXjPaIGpQPGsHHLBg147RVijgqxxfnPJhMGmVEyOQ29BbVIuwCk07gspYFVy4omXkjvdPcBK2yAhHhsA-y9aD1UWqcOl5c2ZZTdmkbv1vyu62pdboPSWe1bKQ23rhftw_HtmWkGPgs5oI37LLO7tlUe4flfjsHbFzqN1YIw0l0JzN9-N5dxkVKOy9uEapbukchzCStxT7sNHOn-4mSC4Rcabr338P6Bpv0qWG-7UNvdX0bDhAqrYpDWP_xyA_jgngCOSUQxg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7RrdRyQfQFy6N1pV7TXcd27HBDCLRtWS4FiZvleL1SEGxWsAuc-O3MOA9UqYiqlxxij5JMbM-X-JtvAL4NAy-0yTyJD_pEGqkSJ8UQD1mhJor7NGrpjU-y0Zn8ea7OV-CgzYUhWmWz9tdrelytmzODxpuDeVkOfpOyCw7YHCHIkGDMK3gtldDE6_v-8MTzELKussmJbYvd2_y5SPJyVxfVgnIAeR5lPKmK3d_j03P4M8aho3VYawAk26_v8R2shNl7eDNutsg_QBgTxe7O3Qbmiprotsf2GaJn1um1MkSqDJEfw6uhmy9johS76pgwrJqyclJWsVyxZ9f0T55UnFiYE9y8L28-wtnR4enBKGlqKSReSrFIPMbtCYKBrJAY4guufZ6mLhjlETNIHxRCj2kwcsppoxRRVI6fzXkwWhhp0qDFJ-jNqlnYBCZcipNaFFy6IIX2RninuAlK6gLx4LAPovWg9Y3QONW7uLQto-zC1n635HcbiXWqD0lnNa-FNl7or9qXY9skUlz2LEaCF-x0Z_fHQPsHy512DNhmot_YNDWcJHe06cPXrhmnKO27uFmoltRHIsgkpcU-bNRjp3tEwVMEXFm29d-39QXejk7Hx_b4x8mvbVillpoDtwO9xfUy7CJoWhSf46R4BIhhEZE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microwave+ablation%3A+A+new+technique+for+the+prophylactic+management+of+idiopathic+recurrent+epistaxis&rft.jtitle=American+journal+of+otolaryngology&rft.au=Lou%2C+Zheng-cai&rft.date=2019-09-01&rft.pub=Elsevier+Inc&rft.issn=0196-0709&rft.eissn=1532-818X&rft.volume=40&rft.issue=5&rft.spage=696&rft.epage=699&rft_id=info:doi/10.1016%2Fj.amjoto.2019.06.005&rft.externalDocID=S0196070919303977 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0196-0709&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0196-0709&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0196-0709&client=summon |